Accretion Nutraveda Limited
Latest filings
Next results: Sat, 31 Oct · Financial Results- Board to approve half-year results on 31 October 2026 · Results
- Accretion Nutraveda shareholders approve MOA amendments expanding business scope · General
- All 5 special resolutions passed with 100 percent approval via postal ballot · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
Manufactures ayurvedic and nutraceutical products from a facility at Xcelon Industrial Park in Ahmedabad, Gujarat, and also offers CDMO (contract development and manufacturing) services to other companies. FY26 revenue was Rs. 33.60 crore, up 110% from Rs. 16.00 crore in FY25, with growth driven by demand for its nutraceutical and ayurvedic products, an expanded customer base, a richer product mix and higher CDMO contribution. Profit after tax was Rs. 5.07 crore on EBITDA of Rs. 7.01 crore. The business runs on a very raw-material-heavy cost structure: materials accounted for 73.6% of FY26 revenue, against just 3.2% for employees and 4.6% for other operating expenses. It follows an export-led strategy, winning a Global Export Excellence Award in Ayurvedic and Nutraceutical Manufacturing, and is working on product registrations and market approvals in international markets. The company raised Rs. 24.77 crore through an IPO and listed on the BSE SME platform in February 2026, using Rs. 7.04 crore of the proceeds on machinery, Rs. 5.24 crore on working capital, Rs. 3.69 crore on corporate purposes and Rs. 3.33 crore on IPO expenses, with Rs. 6.55 crore still unutilised.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from Accretion Nutraveda Limited's filed financials and exchange disclosures
What does Accretion Nutraveda Limited do?
Accretion Nutraveda Limited is a Pharmaceuticals & Biotechnology company listed on BSE.
How much does the Accretion Nutraveda Limited share price move in a day?
On a typical session Accretion Nutraveda Limited moves 2.67% — that is the median absolute close-to-close move across its last 132 trading days. MarketPing measures each filing's price reaction against it.
When are Accretion Nutraveda Limited's next results?
Financial Results on Sat, 31 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track Accretion Nutraveda Limited's announcements?
Every NSE and BSE filing by Accretion Nutraveda Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.